Overexpression of CDC20 was observed in a variety of human tumors including pancreatic cancer, breast cancer, prostate cancer, lung cancer, colorectal cancer, hepatocellular carcinoma, glioblastoma, gastric cancer, and other types of human cancer (24–27). This evidence concerns the gene CDC20 and breast carcinoma.